![](/img/cover-not-exists.png)
Controlling complement 5a (C5a) in disease setting requires a specifically targeted inhibition
Guo, Renfeng, Habel, Maria, Ziereisen, Jana, Hermann, Marlen, Xu, Zhongli, Zenker, Othmar, Kirschfink, Michael, Riedemann, NielsVolume:
102
Language:
english
Journal:
Molecular Immunology
DOI:
10.1016/j.molimm.2018.06.085
Date:
October, 2018
File:
PDF, 45 KB
english, 2018